Table 1 Baseline characteristics of 172 eligible and evaluable patients
Characteristic | Total, n = 172 |
|---|---|
Age at diagnosis (years) | |
Median (IQR) | 55.2 years (46.8–63.5 years) |
Gender | |
Female | 96 (54.2%) |
Male | 81 (45.7%) |
Soft tissue sarcoma subtype | |
Leiomyosarcoma | 75 (43.6%) |
Liposarcoma | 19 (11.0%) |
Undifferentiated pleomorphic sarcoma | 13 (7.6%) |
Synovial sarcoma | 10 (5.8%) |
Myxofibrosarcoma | 8 (4.7%) |
Solitary fibrous tissue | 6 (3.5%) |
Angiosarcoma | 5 (2.9%) |
Malignant peripheral nerve sheath tumour | 5 (2.9%) |
Soft tissue sarcoma (NOS) | 5 (2.9%) |
High grade pleomorphic sarcoma (NOS) | 4 (2.3%) |
Spindle cell sarcoma (NOS) | 3 (1.7%) |
Extra skeletal myxoid chondrosarcoma | 3 (1.7%) |
Endometrial stromal sarcoma | 2 (1.2%) |
Adenosarcoma | 2 (1.2%) |
PEComa | 1 (0.6%) |
Intimal sarcoma | 1 (0.6%) |
Sites of metastatic disease | |
Lung | 88 (51.2%) |
Liver | 31 (18.0%) |
Soft tissue | 25 (14.5%) |
Bone | 21 (12.2%) |
Pelvis | 14 (8.1%) |
Abdominal | 13 (7.6%) |
Peritoneal | 11 (6.4%) |
Lymph nodes | 4 (2.3%) |
Cardiac | 3 (1.7%) |
Intracranial | 3 (1.7%) |
Renal | 2 (1.2%) |
Pancreas | 1 (0.6%) |
Unknown | 39 (22.7%) |